Clara Masó Albareda2026-02-23T17:22:23+01:00

Clara Masó Albareda

Member of the Research Line Wound healing innovation

ORCID: 0000-0002-8633-2836

Scientific Profile: URECERCA

She is a Physical Therapist from the University of Vic – Central University of Catalonia (2015), a Nurse from the University of Vic – Central University of Catalonia (2018), and holds a Master’s degree in Comprehensive Management and Research of Chronic Wounds in University of Cantabria (2019). She first started in the field of chronic wounds with the completion of the Final Degree Project (TFG) in collaboration with the TR2Lab research group.

As a wound-specialised nurse with a certification from the Spanish advisory group for the study of pressure ulcers and chronic wounds (GNEAUPP), Clara works in a Clinical Wound Unit of an intermediate hospital where, for two decades, has been focused on the treatment of difficult-to-heal ulcers with the application of advanced therapies. Thereby, their expertise lies in autologous therapies such as PRP therapy, having participated in a granted project, and punch skin graftings. The latter is due to her doctoral thesis “Observational study of the effect of therapy with punch skin graftings in the treatment of complex skin wounds” with an industrial doctorate and a research intensification grant.

Within the TR2Lab group, she develops her activity in the research line of wound healing innovation (November 2019-present), that have as a long-term goal to be capable of innovating in novel individualized therapies and in improving the assistance organizational processes to increase the rate of healing cutaneous chronic wounds in the Clinical Wound Unit.

My last happenings:

TR2Lab Invited at Congresso de Feridas Guarda 2026

Clara Masó Albareda, PhD student at TR2Lab, was invited to participate in the Congresso de Feridas Guarda 2026, held in Guarda, Portugal, on 14–15 October 2026. As part of the scientific programme, Clara delivered an invited lecture in the session “Tempo da Inovação – Hot Topics”, where she presented the latest findings from her doctoral research on regenerative therapies and their potential applications in wound healing. Her presentation provided attendees with an overview of the most recent results of her PhD project and highlighted the ongoing research being conducted at TR2Lab. In addition to the lecture, Clara [...]

November 4, 2026|

Exploiting Hormesis for Plasma-treated Hydrogel Therapeutic platforms (HormeTic)

Subprojects: Subproject 1: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for cancer treatment (HormOnc)". Subproject 2: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal)". Original Title (English): Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal). Objective: Innovating in the healing of complex wounds. TR2Lab research team members: Albert Espona-Noguera (Principal Investigator). Cristina Canal (PI1 of Subproject 1) & Francesco Tampieri (PI2 of Subproject 1). Members of TR2Lab who participate in this project: Elisabet Sarri, Laia Bosch, Gemma Sangüesa, Francesc Sant Masoliver, Cristina Martin Mancera, David Benito Guasch, Clara Masó [...]

October 20, 2026|

Bringing Science Closer to the Classroom for a Second Consecutive Year during European Researchers’ Night 2026

As part of European Researchers' Night 2026, PhD candidate Clara Masó once again visited Els Castanyers School in Viladrau to bring science closer to young students. For the second consecutive year, pupils from 3rd, 4th and 5th grade took part in interactive workshops designed to introduce them to scientific research, health, hygiene, microorganisms and the scientific method through hands-on activities and discussion. During the first visit, Clara introduced pupils to several key scientific concepts, including the scientific method, the contributions of women in science, how wounds heal and why some wounds fail to heal, advanced wound therapies used in [...]

September 28, 2026|
Go to Top